Masahiro Shimokawa

5PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
Association of Prior Local Therapy with Outcomes Within Systemic Therapy Regimen Cohorts in Advanced Soft Tissue Sarcoma: A Retrospective Cohort Study.

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Dec 30, 2025
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study.

Risako Suzuki, Ryotaro Ohkuma, Makoto Watanabe

|Apr 25, 2022
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma.

Norifumi Iseda, Shinji Itoh, Katsuya Toshida

|Dec 01, 2020
Molecular and immunological paradigms of hepatocellular carcinoma: Special reference to therapeutic approaches.

Ayano Kabashima, Shu Shimada, Masahiro Shimokawa

Pageof 1

Frequent Collaborators

3 joint publications

Takuya Tsunoda

3 joint publications

Atsushi Horiike

3 joint publications

Satoshi Wada

2 joint publications

Go Ikeda